Spun bonded replacement for resin-bonded filters
A superior alternative filter solution for manufacturing processes using resin-bonded filter cartridges.
Amazon Filters has introduced a new variant of its VisClear spun bonded cartridge as a superior alternative filter solution for manufacturing processes using resin-bonded filter cartridges.
While resin-bonded filters have traditionally been a product of choice because they can withstand high differential pressure and temperatures, increasingly health and safety considerations are driving users to look for alternatives. Whatever the operating conditions of the production processes, Amazon Filters offers different configurations of its VisClear cartridge filter to protect processes without needing to change existing filter housings.
VisClear spun-bonded filter cartridges have been specifically designed to operate in the chemical processing and manufacturing industries. Manufactured using Amazon Filters unique fibre processing system, they offer controlled performance and minimal fibre shed – an absolute requirement in the world of high-tech chemistry. Offering a high void volume and integral support core for maximum strength, VisClear filters show excellent performance in terms of life and cost effectiveness. The superior structure of VisClear filters is ideal for high temperature, high viscosity applications, and will remain integral even under severe operating conditions and is not prone to fibre shed.
Amazon Filters is not only able to provide existing users of resin-bonded filter cartridges with full technical assistance to choose the best replacement product from its portfolio but is also able to look at manufacturing quickly new product variants for specific problems.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.